NCT02759796

Brief Summary

It is a single-center, prospective, randomized and controlled study focused in microsurgical autologous breast reconstruction. It involves applying indocyanine green (ICG) angiography for the study of the vascularization of DIEP flaps. The aim of the study is to determine whether there are differences in complications and aesthetic results when ICG is used to discard the poorly vascularized areas of the flap. The study includes adult women undergoing unilateral DIEP flap breast reconstruction. The calculated sample size is 60 patients. There are two groups. In group 1, the investigators use the usual clinical criteria to discard the poorly vascularized areas of the flap. In group 2, the investigators use the ICG to shape the flap.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2016

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 3, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

April 24, 2017

Status Verified

April 1, 2017

Enrollment Period

1.4 years

First QC Date

April 5, 2016

Last Update Submit

April 21, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants with fat necrosis as assessed by physical examination

    Six months postoperatively

  • Number of participants with fat necrosis as assessed by ultrasonography

    Six months postoperatively

Secondary Outcomes (10)

  • Number of participants with flap failure as assessed by physical examination

    From intraoperative moment to one week postoperatively

  • Number of participants with wound infection as assessed by physical examination

    From one day postoperatively to two weeks postoperatively

  • Number of participants with wound healing delay as assessed by physical examination

    From two weeks postoperatively to two months postoperatively

  • Number of participants with reoperation

    From immediate postoperative moment to one year postoperatively

  • Flap perfusion index as assessed by IC-CALC software (Pulsion Medical System)

    Intraoperatively

  • +5 more secondary outcomes

Study Arms (2)

Clinical assessment of flap perfusion

PLACEBO COMPARATOR

Tailoring the flap according to clinical assessment of flap perfusion

Procedure: Tailoring the flap according to clinical assessment

Angiography assessment of flap perfusion

EXPERIMENTAL

Tailoring the flap according to ICG Angiography assessment of flap perfusion

Procedure: Tailoring the flap according to ICG Angiography assessment

Interventions

After microvascular anastomosis is performed, the investigators clinically assess flap vascularization and the well vascularized tissue is marked by means of a dermographic pencil. Then the investigators administer 0,2mg/kg of ICG intravenously. The vascularization of the flap is also checked by means of the Photo Dynamic Eye (Pulsion Medical System) but finally the decision of discarding the poorly vascularized areas of the flap is made by clinical assessment.

Clinical assessment of flap perfusion

After microvascular anastomosis is performed, the investigators administer 0,2mg/kg of ICG intravenously. Then the investigators check the vascularization of the flap by means of the Photo Dynamic Eye (Pulsion Medical System) and the poorly vascularized areas of the flap are discarded guided by ICG perfusion test.

Angiography assessment of flap perfusion

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mastectomized adult female patient
  • Abdominal flap unilateral breast reconstruction indication
  • Alloplastic breast reconstruction sequelae
  • Enough amount of abdominal dermofat tissue to shape a breast with a primary closure of the donor site

You may not qualify if:

  • DIEP flap bilateral breast reconstruction indication
  • Previous abdominoplasty surgery
  • Untreated psychiatric disease
  • Untreated infection
  • Indocyanine green or iodine hypersensitivity
  • Hyperthyroidism, thyroid adenoma or thyroid autonomy
  • Any concomitant disease or condition that, in the opinion of the investigator, can make the patient unsuitable to receive a microsurgical technique or to join the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

La Paz University Hospital

Madrid, 28046, Spain

Location

Related Publications (1)

  • Varela R, Casado-Sanchez C, Zarbakhsh S, Diez J, Hernandez-Godoy J, Landin L. Outcomes of DIEP Flap and Fluorescent Angiography: A Randomized Controlled Clinical Trial. Plast Reconstr Surg. 2020 Jan;145(1):1-10. doi: 10.1097/PRS.0000000000006393.

MeSH Terms

Conditions

Breast NeoplasmsNeovascularization, PathologicFat Necrosis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesMetaplasiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Luis Landín Jarillo, MD, PhD

    La Paz University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2016

First Posted

May 3, 2016

Study Start

November 1, 2015

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

April 24, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations